Shopping Cart
- Remove All
- Your shopping cart is currently empty
IZCZ-3,antitumor activity. is a potent c-MYC transcription inhibitor.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,230 | 6-8 weeks | |
50 mg | $1,610 | 6-8 weeks | |
100 mg | $2,390 | 6-8 weeks |
Description | IZCZ-3,antitumor activity. is a potent c-MYC transcription inhibitor. |
In vitro | IZCZ-3 induces only weak growth inhibition in the BJ fibroblasts (IC50=15.9 μM) and mouse mesangial cells (IC50=15.6 μM), suggesting that IZCZ-3 is more effective against cancer cells than against c-MYC-independent normal cells. IZCZ-3 (0-5 μM; 12 hours) induces an apparent accumulation of cells in the G0/G1 phase in SiHa cells in a dose-dependent manner.IZCZ-3 (2.1 μM-15.9 μM; 24 hours) significantly inhibits SiHa, HeLa, Huh7, and A375 cancer cell proliferation (IC50s of 3.3, 2.1,4.1, and 4.2 μM, respectively). |
In vivo | IZCZ-3 inhibits tumor growth in BALB/c nude mice with SiHa human cervical squamous cancer xenograft. |
Molecular Weight | 715.93 |
Formula | C46H49N7O |
Cas No. | 2223019-53-0 |
Relative Density. | 1.31g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||
Solubility Information | DMSO: 5 mg/mL (6.98 mM), Sonication and heating to 80℃ are recommended. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.